Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Placebo controlled evaluation of effectiveness of nicotine acid in treatment of postprandial
dyslipidemia in patients with metabolic syndrome. Nicotine acid decreases postprandial
hyperlipidaemia in patients with metabolic syndrome which reduces the low-grade inflammation
and the risk of atherosclerosis.
Phase:
Phase 3
Details
Lead Sponsor:
GWT-TUD GmbH
Collaborators:
Technische Universität Dresden University of Regensburg